Nvidia, reconsidered

Date:

Share post:


Receive free US & Canadian companies updates

This article is an on-site version of our Unhedged newsletter. Sign up here to get the newsletter sent straight to your inbox every weekday

Good morning. The Atlanta Fed’s estimate of third-quarter GDP, which has looked improbably high, just keeps rising. It ticked up to 5.9 per cent yesterday. One contributor: a 0.5 percentage point boost from sold-out Taylor Swift and Beyoncé concerts plus the Barbenheimer phenomenon, according to Bloomberg Economics estimates. We await Jay Powell’s comments on this at Jackson Hole today. Email us: [email protected] and [email protected]

Nvidia’s valuation, reconsidered

A week or two ago, I wrote a piece which suggested that Nvidia’s valuation might be overextended. After the company’s second-quarter earnings report on Wednesday afternoon and the market response yesterday, I feel half vindicated.

The earnings report was an absolute monster. The results were miles ahead of expectations and the outlook was too. The company expects $16bn in revenues in the third quarter; in the year ago period, revenue was $5.9bn. The company is growing like wildfire. But the stock responded by rising by all of a tenth of a per cent yesterday. That suggests that all the good news was already in the price, or in other words, that the shares might be near a valuation ceiling, for now.

I only feel half vindicated because Nvidia’s growth is so strong that I have to reconsider my argument that the stock is gripped by irrational exuberance, in something like the way Cisco shares were in 1999-2000. Cisco’s stock became so inflated that it has still not returned to the highs it hit back then, despite 23 years of great performance. But Cisco never grew the way Nvidia is growing now, so Nvidia’s valuation may make more sense than I assumed.

A little rough maths makes the valuation picture clearer. Let’s say the company makes $3.25 in net income per share this quarter, on a GAAP basis. Given the revenue guidance, this seems eminently possible. Annualise that, and the company is earning $13 a year. At the current price, that’s a forward price/earnings ratio of 36. Apple is at 27 and it is increasing revenue at a low single-digit pace. The S&P 500 is at 20. Relative to its growth, one might argue, Nvidia is cheaper than Apple or even the market. What this week’s earnings report showed was that while Nvidia’s valuation is high, it is absolutely not dotcom-crazy. (You could argue, of course, that Apple is overvalued, or that big tech is, or that the whole market is; maybe so; but what we are talking about here is relative valuation.)

The degree of Nvidia’s growth is undeniable. What about its stability?

It can appear that Nvidia’s competitive position in AI chips is unassailable, and not simply because they are better at the heavy parallel processing AI requires. Its “full-stack” products, which integrate chip design, hardware and software, are the only right-out-of-the-box solution for companies that want to add AI capabilities quickly. By the time rival chipmakers such as Intel and AMD catch up on parallel-processing chips, Nvidia’s installed base will represent an uncrossable competitive moat — something like Intel’s position in personal computing years ago with its x86 processor. 

A conversation with Gartner AI analyst Chirag Dekate convinced me that there is another way to look at it. In a certain sense, Nvidia’s principal competitors are not other chipmakers, but the big computing platforms: Amazon Web Services, Microsoft Azure and Google Cloud. These companies plan to both use AI in their own services and sell AI capabilities to customers.

Crucially, the platform companies compete on cost, and the way for them to deliver low-cost AI capacity and services is by using the computing infrastructure they already have in place. In other words, their incentive is to offer customers diverse options including both Nvidia’s out-of-the-box, highly specialised products and their own in-house technology, which can handle AI work and all the other kinds of computing work they and their customers do. And the platforms’ own purpose-built AI infrastructure could, potentially, offer more computing bang for the corporate buck. 

“If a platform uses Nvidia across the board, their cost advantage could dissipate. The only way they have a cost advantage over time is if they start eking costs from the infrastructure layers, exploring alternative pathways to efficiency,” Dekate says. He thinks that Nvidia alternatives will offer enterprises more flexibility and, potentially, superior price-performance trade-offs as soon as next year. The AI chip market is still up for grabs. “You don’t declare winners after the first inning,” he says.

Bearing this in mind, the issue is less whether Nvidia looks badly overvalued now, relative to peers or the wider market. I no longer think it does. The question is how it looks in, say, two years’ time. The answer depends on how AI services are being delivered in 2025. If you can forecast that with any confidence, by all means, email me. 

One good read

You really don’t want to be in the “quantitative eject seat”.

FT Unhedged podcast

https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fdfee3b6d 9e31 411d 9bdf ba4b484346d9

Can’t get enough of Unhedged? Listen to our new podcast, hosted by Ethan Wu and Katie Martin, for a 15-minute dive into the latest markets news and financial headlines, twice a week. Catch up on past editions of the newsletter here.

Swamp Notes — Expert insight on the intersection of money and power in US politics. Sign up here

The Lex Newsletter — Lex is the FT’s incisive daily column on investment. Sign up for our newsletter on local and global trends from expert writers in four great financial centres. Sign up here



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Trio awarded Nobel physics prize for advances in electron dynamics

Receive free Nobel prizes updatesWe’ll send you a myFT Daily Digest email rounding up the latest Nobel...

European VC firm Atomico raises $1.1bn to defy tech slowdown

Receive free Atomico Investment Holdings Ltd updatesWe’ll send you a myFT Daily Digest email rounding up the...

Britain is Europe’s haven from the hard right

Receive free Populism updatesWe’ll send you a myFT Daily Digest email rounding up the latest Populism news...

Boohoo slashes profits forecast as consumers cut back

Receive free Boohoo.Com PLC updatesWe’ll send you a myFT Daily Digest email rounding up the latest Boohoo.Com...

Singapore considers money-laundering checks for luxury cars and handbags

Receive free Singapore updatesWe’ll send you a myFT Daily Digest email rounding up the latest Singapore news...

India and south Asia forecast to grow more quickly than other regions

Receive free Asia-Pacific economy updatesWe’ll send you a myFT Daily Digest email rounding up the latest Asia-Pacific...

Nagorno-Karabakh shows that Russia has lost control of its near-abroad

Receive free Armenia-Azerbaijan conflict updatesWe’ll send you a myFT Daily Digest email rounding up the latest Armenia-Azerbaijan...

Rishi Sunak is right: multiculturalism works

Receive free UK society updatesWe’ll send you a myFT Daily Digest email rounding up the latest UK...